Important development: FEMTECH subsidiary OCON Healthcare of the Merchavia Investments Group inked an exclusive deal with BioGenuine

The Israeli FEMTECH company OCON Healthcare, part of the Merchavia Holdings and Investments (TASE: MRHL) group of companies, has announced that it has reached a legally binding agreement with BioGenuine, a Chinese pharmaceutical company specialising in women's health. BioGenuine will start marketing its products exclusively in China and Southeast Asia.

Additionally, it is stated that the firms would cooperate in the development a....